Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03429400 · ClinicalTrials.gov registry record · Phase 3
Study of Oral Morphine Sulfate Administration in Pediatric Subjects
A Phase 3 study of Pain, Postoperative, sponsored by West-Ward Pharmaceutical.
- Completed
- Registry status
- Phase 3
- Development phase
- 51
- Enrollment target
- 1
- Study location
NCT03429400: Completed Phase 3 study of Pain, Postoperative, sponsored by West-Ward Pharmaceutical.
NCT03429400 is a Phase 3 study of Pain, Postoperative that has completed, run by West-Ward Pharmaceutical. The registered enrollment target is 51 participants, below the 273-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03429400, a Phase 3 study of Pain, Postoperative, has completed, sponsored by West-Ward Pharmaceutical.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 51 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a multicenter, open-label study to evaluate the safety and PK of oral morphine sulfate in pediatric subjects with post-operative pain.
Primary Outcome
Eight PK samples will be collected within the first 24 hours after the first dose
Conditions Studied
Interventions
- DRUG Morphine Sulfate
Study Locations (1)
Alabama
- Site 105 - Sheffield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2018-04-17 |
| Est. Completion | 2019-05-29 |
| Phase | Phase 3 |
What the finished NCT03429400 record still lists
NCT03429400 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 273-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Pain, Postoperative appearing as the primary indexed condition, and to 1 intervention - of which Morphine Sulfate is the first listed.
NCT03429400 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT03429400 about?
NCT03429400 is a clinical study titled "Study of Oral Morphine Sulfate Administration in Pediatric Subjects". This is a multicenter, open-label study to evaluate the safety and PK of oral morphine sulfate in pediatric subjects with post-operative pain.
What is the current status of trial NCT03429400?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 51 participants. The study started on 2018-04-17. Estimated completion is 2019-05-29.
What conditions does trial NCT03429400 study?
This clinical trial studies the following conditions: Pain, Postoperative.
What interventions are being tested in trial NCT03429400?
The interventions under investigation include: Morphine Sulfate (DRUG).
Who is sponsoring clinical trial NCT03429400?
This trial is sponsored by West-Ward Pharmaceutical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03429400 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03429400's enrollment target sits among peer trials
51 89th of 113 higher than 25 of 113 other Pain, Postoperative trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
RECRUITING · Phase 3
-
Opioid-Free Orthopaedics
RECRUITING · Phase 3
-
Evaluate Efficacy and Safety of Extended Release (ER) Naproxen Sodium
COMPLETED · Phase 3
-
Bilateral Continuous Erector Spinae Blocks for Post-Sternotomy Pain Management: A Pilot Study
COMPLETED · Phase 3
-
Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery
COMPLETED · Phase 3
-
Safety and Clinical Utility Study of SSEC Fentanyl 40 mcg for Acute Post-op Pain Management in Pediatric Participants
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI